The company aims to develop, manufacture, produce, store, sell and/or distribute biogenic chemical products and product formulations containing such biogenic chemical products, as well as to provide consulting services regarding the development of new technologies in this field. The company may establish branches and subsidiaries in Switzerland and/or abroad and invest in other companies in Switzerland and/or abroad, acquire, hold, encumber and dispose of real estate in Switzerland and/or abroad as well as conduct all commercial, financial or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing, with or without consideration, to its direct or indirect parent companies and their direct or indirect subsidiaries as well as to third parties, including its direct or indirect shareholders, and provide security of any kind for the liabilities of such persons or group companies, including guarantees, pledges and fiduciary transfers of the company's assets. In addition, it may engage in or participate in liquidity equalization/net liquidity centralization (cash pooling), including periodic balance adjustments (balancing), with group companies, also without consideration, on preferential terms, interest-free, excluding the company's profit-making intention and assuming clumping risks.